182
Participants
Start Date
February 25, 2022
Primary Completion Date
April 29, 2024
Study Completion Date
April 29, 2024
Gene Profile explore
The tissue and blood sample for this genetic research will be obtained from the participants at baseline(disease progression after 1L Osimertinib). Paired tissue and whole blood sample should be collected per participant for genetics during the study.
Research Site, Beijing
Research Site, Dalian
Research Site, Harbin
Research Site, Shanghai
Research Site, Taizhou
Research Site, Hefei
Research Site, Hefei
Research Site, Rizhao
Research Site, Tianjin
Research Site, Linhai
Research Site, Fuzhou
Research Site, Changsha
Research Site, Zhengzhou
Research Site, Luoyang
Research Site, Foshan
Research Site, Chengdu
Lead Sponsor
AstraZeneca
INDUSTRY